期刊文献+

高效液相法测定依折麦布片的含量 被引量:10

Determination of Ezetimibe in Ezetimibe Tablets by HPLC
下载PDF
导出
摘要 建立了依折麦布片含量测定方法。采用高效液相色谱法测定依折麦布的含量。色谱柱为C18(5μm,4.6 mm×250 mm),流动相为乙腈-0.05%庚烷磺酸钠水溶液(65∶35),检测波长232 nm,流速1.0 mL/min。结果表明:依折麦布浓度在2~20μg/mL范围内,峰面积与浓度线性关系良好,平均回收率为99.4%(RSD=0.53%)。结果该法简便、准确、灵敏度高重现性好,可用于依折麦布的含量测定。 The HPLC method for determination of Ezetimibe in Ezetimibe tablets was established. The assay involved an isocratic elution of ezetimibe in a Cls column(5μm,4.6 mm×250 mm) , using a mobile phase composition of acetonitrile and 0.05% sodium heptanesulfonate(65 : 35 ). The determination wavelength was 232 nm and the flow rate was 1.0 mL/min. The result showed ezetimibe had a linear range of 2 - 20 μg/mL with a mean recovery of 99.4% ( RSD = 0.53% ). The method was convenient, accurate, and sensitive. It can be used for the determination of ezetimibe.
作者 邱思婕
出处 《广州化工》 CAS 2012年第16期134-135,共2页 GuangZhou Chemical Industry
关键词 依折麦布 高效液相色谱法 含量测定 Ezetimibe HPLC determination
  • 相关文献

参考文献2

  • 1Sudhop T, Lujohann D, KordaL A, et al. Inhibition of intestinaL choLes- teroL absorption by ezetimibe in humans [ J ]. CircuLation, 2002,108 ( 1 ) : 1943 - 1948.
  • 2国家药典委员会.中国药典·二部[S].北京:化学工业出版社,2010.

同被引文献74

  • 1许沧,杨红,余蓉,杨中柱.HPLC法测定药品辛伐他汀含量[J].四川省卫生管理干部学院学报,2006,25(2):81-82. 被引量:2
  • 2国家药典委员会编.中国药典.二部.[S].北京:化学工业出版社,2010:附录107.
  • 3国家药典委员会.中国药典·二部[s].北京:中国医药出版社,2010:附录35,附录H.
  • 4Bays H, Sapres A, Taggart IW. Long-term (48- week ) safety of ezetimibe 10rag/day coadministered with simvastatin compared to simvastatin alone in patientq with primm7 hypercholesterolemia[J].Curr Med Res Opin, 2008,24 ( 10 ): 2953-2966.
  • 5Masana L, Mata P, Gagne C.L0ng-term safety and, tolerability pro-files andlipid-modifying eficacy of ezetinfibe coadministered with ongoing simvastatin treatment: A multicenter, randomized, doubleo blind : placebo, controlled,48-Week extension study[J].Clin Ther,2005,27 ( 2 ) : 174-184.
  • 6ICH Q2A.Test on Validation of Analytical Procedures.1996.
  • 7ICH Q2B.Validation of Analytical Procedures: Methodology, 1996.
  • 8化学药物质量控制分析方法验证技术指导原则[s].2005:3.
  • 9FDA.Guidance for Industry: analytical procedures and methods validation, chemistry, manufacturing, and controls documentation ( Draft ), 2000,8,.
  • 10熊祯,翟所迪,陈凤荣.新型血脂调节药——依折麦布[J].中国新药与临床杂志,2007,26(11):864-868. 被引量:23

引证文献10

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部